185 related articles for article (PubMed ID: 37882248)
1. Glycoproteomic contributions to hepatocellular carcinoma research: a 2023 update.
Zheng Y; Gao K; Gao Q; Zhang S
Expert Rev Proteomics; 2023; 20(10):211-220. PubMed ID: 37882248
[TBL] [Abstract][Full Text] [Related]
2. Surface glycoproteomic analysis of hepatocellular carcinoma cells by affinity enrichment and mass spectrometric identification.
Mi W; Jia W; Zheng Z; Wang J; Cai Y; Ying W; Qian X
Glycoconj J; 2012 Aug; 29(5-6):411-24. PubMed ID: 22752401
[TBL] [Abstract][Full Text] [Related]
3. [Recent advances in glycopeptide enrichment and mass spectrometry data interpretation approaches for glycoproteomics analyses].
Liu L; Qin H; Ye M
Se Pu; 2021 Oct; 39(10):1045-1054. PubMed ID: 34505426
[TBL] [Abstract][Full Text] [Related]
4. Recent Advances of Functional Proteomics in Gastrointestinal Cancers- a Path towards the Identification of Candidate Diagnostic, Prognostic, and Therapeutic Molecular Biomarkers.
Abyadeh M; Meyfour A; Gupta V; Zabet Moghaddam M; Fitzhenry MJ; Shahbazian S; Hosseini Salekdeh G; Mirzaei M
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33198323
[TBL] [Abstract][Full Text] [Related]
5. Integrating transcriptomics, glycomics and glycoproteomics to characterize hepatitis B virus-associated hepatocellular carcinoma.
Li Z; Zhang N; Dong Z; Wang X; Zhou J; Gao J; Yang Y; Li J; Guan F; Zhou Y; Tan Z
Cell Commun Signal; 2024 Apr; 22(1):200. PubMed ID: 38561745
[TBL] [Abstract][Full Text] [Related]
6. Protein glycosylation alterations in hepatocellular carcinoma: function and clinical implications.
Wang Y; Chen H
Oncogene; 2023 Jun; 42(24):1970-1979. PubMed ID: 37193819
[TBL] [Abstract][Full Text] [Related]
7. Glycoproteomic markers of hepatocellular carcinoma-mass spectrometry based approaches.
Zhu J; Warner E; Parikh ND; Lubman DM
Mass Spectrom Rev; 2019 May; 38(3):265-290. PubMed ID: 30472795
[TBL] [Abstract][Full Text] [Related]
8. Lectin-based glycoproteomics to explore and analyze hepatocellular carcinoma-related glycoprotein markers.
Dai Z; Zhou J; Qiu SJ; Liu YK; Fan J
Electrophoresis; 2009 Sep; 30(17):2957-2966. PubMed ID: 19711376
[TBL] [Abstract][Full Text] [Related]
9. Protein glycosylation in viral hepatitis-related HCC: Characterization of heterogeneity, biological roles, and clinical implications.
Zhang S; Cao X; Gao Q; Liu Y
Cancer Lett; 2017 Oct; 406():64-70. PubMed ID: 28789967
[TBL] [Abstract][Full Text] [Related]
10. Identification of N-glycosylation in hepatocellular carcinoma patients' serum with a comparative proteomic approach.
Huang Y; Wu H; Xue R; Liu T; Dong L; Yao J; Zhang Y; Shen X
PLoS One; 2013; 8(10):e77161. PubMed ID: 24143209
[TBL] [Abstract][Full Text] [Related]
11. Use of targeted glycoproteomics to identify serum glycoproteins that correlate with liver cancer in woodchucks and humans.
Block TM; Comunale MA; Lowman M; Steel LF; Romano PR; Fimmel C; Tennant BC; London WT; Evans AA; Blumberg BS; Dwek RA; Mattu TS; Mehta AS
Proc Natl Acad Sci U S A; 2005 Jan; 102(3):779-84. PubMed ID: 15642945
[TBL] [Abstract][Full Text] [Related]
12. Advances in LC-MS/MS-based glycoproteomics: getting closer to system-wide site-specific mapping of the N- and O-glycoproteome.
Thaysen-Andersen M; Packer NH
Biochim Biophys Acta; 2014 Sep; 1844(9):1437-52. PubMed ID: 24830338
[TBL] [Abstract][Full Text] [Related]
13. Precision N-glycoproteomics reveals elevated LacdiNAc as a novel signature of intrahepatic cholangiocarcinoma.
Li J; Zhao T; Li J; Shen J; Jia L; Zhu B; Dang L; Ma C; Liu D; Mu F; Hu L; Sun S
Mol Oncol; 2022 Jun; 16(11):2135-2152. PubMed ID: 34855283
[TBL] [Abstract][Full Text] [Related]
14. Integrated plasma proteomics and N-glycoproteomics reveals alterations in the N-glycosylation in Chinese hepatocellular carcinoma patients.
Zeng J; Rong W; Meng B; Zheng L; Peng T; Zhai R; Jiang Y; Xiao T; Fang X; Zhang Y; Zhao Y; Dai X
Proteomics Clin Appl; 2024 Feb; ():e2300029. PubMed ID: 38345243
[TBL] [Abstract][Full Text] [Related]
15. Chemical Glycoproteomics.
Palaniappan KK; Bertozzi CR
Chem Rev; 2016 Dec; 116(23):14277-14306. PubMed ID: 27960262
[TBL] [Abstract][Full Text] [Related]
16. Site-specific glycoproteomic analysis revealing increased core-fucosylation on FOLR1 enhances folate uptake capacity of HCC cells to promote EMT.
Jia L; Li J; Li P; Liu D; Li J; Shen J; Zhu B; Ma C; Zhao T; Lan R; Dang L; Li W; Sun S
Theranostics; 2021; 11(14):6905-6921. PubMed ID: 34093861
[No Abstract] [Full Text] [Related]
17. Genetic alterations in hepatocellular carcinoma: An update.
Niu ZS; Niu XJ; Wang WH
World J Gastroenterol; 2016 Nov; 22(41):9069-9095. PubMed ID: 27895396
[TBL] [Abstract][Full Text] [Related]
18. N-Glycosylation Patterns Correlate with Hepatocellular Carcinoma Genetic Subtypes.
DelaCourt A; Black A; Angel P; Drake R; Hoshida Y; Singal A; Lewin D; Taouli B; Lewis S; Schwarz M; Fiel MI; Mehta AS
Mol Cancer Res; 2021 Nov; 19(11):1868-1877. PubMed ID: 34380744
[TBL] [Abstract][Full Text] [Related]
19. N-glycosylation by N-acetylglucosaminyltransferase IVa enhances the interaction of integrin β1 with vimentin and promotes hepatocellular carcinoma cell motility.
Yang D; Han F; Cai J; Sun H; Wang F; Jiang M; Zhang M; Yuan M; Zhou W; Li H; Yang L; Bai Y; Xiao L; Dong H; Cheng Q; Mao H; Zhou L; Wang R; Li Y; Nie H
Biochim Biophys Acta Mol Cell Res; 2023 Oct; 1870(7):119513. PubMed ID: 37295747
[TBL] [Abstract][Full Text] [Related]
20. Bibliometric study of immunotherapy for hepatocellular carcinoma.
Li Z; Zhang Y; Zhang B; Guo R; He M; Liu ZL; Yang L; Wang H
Front Immunol; 2023; 14():1210802. PubMed ID: 37600802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
